In addition, we analyzed the ARID1A wild-type cell pellet, as well as two tumor tissues in ELISA, to confirm the above-described results, and found similarly low recovery rates, suggesting neither methodical nor technical errors. The gene discussed is ARID1A; the disease is neoplasm.